Concepedia

Tiziano Ongaro

TO

5

Publications

104

Citations

5

H-Index

2018

Active since

Affiliations

Philochem (Switzerland)(Current)

ETH Zurich

Tiziano Ongaro is an author at Philochem (Switzerland) specializing in immunology, immunotherapy, and cell biology.

ORCID

Top concepts

Publications per year

2018–2021

5

Publications

5

A novel anti-cancer L19-interleukin-12 fusion protein with an optimized peptide linker efficiently localizes in vivo at the site of tumors

Tiziano Ongaro, Mattia Matasci, Samuele Cazzamalli et al. · Journal of Biotechnology · 2018 · 35 citations

, , +7

A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis

Riccardo Corbellari, Marco Stringhini, Jacqueline Mock et al. · Molecular Cancer Therapeutics · 2021 · 20 citations · Full text

A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties <i>in vivo</i>

Tiziano Ongaro, Baptiste Gouyou, Marco Stringhini et al. · Oncotarget · 2020 · 19 citations · Full text

A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell Carcinomas

Roberto De Luca, Baptiste Gouyou, Tiziano Ongaro et al. · Frontiers in Oncology · 2019 · 17 citations · Full text

Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade

Sheila Dakhel Plaza, Tiziano Ongaro, Baptiste Gouyou et al. · Oncotarget · 2019 · 13 citations · Full text

Rows per page

1–5 of 5